188 related articles for article (PubMed ID: 14752098)
21. Proton abstraction reaction, steady-state kinetics, and oxidation-reduction potential of human glutaryl-CoA dehydrogenase.
Dwyer TM; Rao KS; Goodman SI; Frerman FE
Biochemistry; 2000 Sep; 39(37):11488-99. PubMed ID: 10985795
[TBL] [Abstract][Full Text] [Related]
22. Role of isovaleryl-CoA dehydrogenase and short branched-chain acyl-CoA dehydrogenase in the metabolism of valproic acid: implications for the branched-chain amino acid oxidation pathway.
Luís PB; Ruiter JP; Ijlst L; Tavares de Almeida I; Duran M; Mohsen AW; Vockley J; Wanders RJ; Silva MF
Drug Metab Dispos; 2011 Jul; 39(7):1155-60. PubMed ID: 21430231
[TBL] [Abstract][Full Text] [Related]
23. Substrate activating mechanism of short-chain acyl-CoA, medium-chain acyl-CoA, long-chain acyl-CoA, and isovaleryl-CoA dehydrogenases from bovine liver: a resonance Raman study on the 3-ketoacyl-CoA complexes.
Hazekawa I; Nishina Y; Sato K; Shichiri M; Shiga K
J Biochem; 1995 Nov; 118(5):900-10. PubMed ID: 8749305
[TBL] [Abstract][Full Text] [Related]
24. Mechanism-based inactivation of human glutaryl-CoA dehydrogenase by 2-pentynoyl-CoA: rationale for enhanced reactivity.
Rao KS; Albro M; Vockley J; Frerman FE
J Biol Chem; 2003 Jul; 278(29):26342-50. PubMed ID: 12716879
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of medium-chain acyl-CoA dehydrogenase from pig liver mitochondria with and without substrate.
Kim JJ; Wang M; Paschke R
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7523-7. PubMed ID: 8356049
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of isovaleric acidemia and medium-chain acyl-CoA dehydrogenase deficiency.
Tanaka K; Ikeda Y; Matsubara Y; Hyman DB
Enzyme; 1987; 38(1-4):91-107. PubMed ID: 3326738
[TBL] [Abstract][Full Text] [Related]
27. A novel approach to the characterization of substrate specificity in short/branched chain Acyl-CoA dehydrogenase.
He M; Burghardt TP; Vockley J
J Biol Chem; 2003 Sep; 278(39):37974-86. PubMed ID: 12855692
[TBL] [Abstract][Full Text] [Related]
28. Purification and properties of short-chain acyl-CoA, medium-chain acyl-CoA, and isovaleryl-CoA dehydrogenases from human liver.
Finocchiaro G; Ito M; Tanaka K
Adv Neurol; 1988; 48():221-30. PubMed ID: 3334784
[No Abstract] [Full Text] [Related]
29. Identification of isobutyryl-CoA dehydrogenase and its deficiency in humans.
Nguyen TV; Andresen BS; Corydon TJ; Ghisla S; Abd-El Razik N; Mohsen AW; Cederbaum SD; Roe DS; Roe CR; Lench NJ; Vockley J
Mol Genet Metab; 2002; 77(1-2):68-79. PubMed ID: 12359132
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial import and processing of wild type and type III mutant isovaleryl-CoA dehydrogenase.
Volchenboum SL; Vockley J
J Biol Chem; 2000 Mar; 275(11):7958-63. PubMed ID: 10713113
[TBL] [Abstract][Full Text] [Related]
31. Purification and characterization of the 2-methyl branched-chain Acyl-CoA dehydrogenase, an enzyme involved in NADH-dependent enoyl-CoA reduction in anaerobic mitochondria of the nematode, Ascaris suum.
Komuniecki R; Fekete S; Thissen-Parra J
J Biol Chem; 1985 Apr; 260(8):4770-7. PubMed ID: 3988734
[TBL] [Abstract][Full Text] [Related]
32. Convergent evolution of a 2-methylbutyryl-CoA dehydrogenase from isovaleryl-CoA dehydrogenase in Solanum tuberosum.
Goetzman ES; Mohsen AW; Prasad K; Vockley J
J Biol Chem; 2005 Feb; 280(6):4873-9. PubMed ID: 15574432
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional structure of butyryl-CoA dehydrogenase from Megasphaera elsdenii.
Djordjevic S; Pace CP; Stankovich MT; Kim JJ
Biochemistry; 1995 Feb; 34(7):2163-71. PubMed ID: 7857927
[TBL] [Abstract][Full Text] [Related]
34. Isolated 2-methylbutyrylglycinuria caused by short/branched-chain acyl-CoA dehydrogenase deficiency: identification of a new enzyme defect, resolution of its molecular basis, and evidence for distinct acyl-CoA dehydrogenases in isoleucine and valine metabolism.
Andresen BS; Christensen E; Corydon TJ; Bross P; Pilgaard B; Wanders RJ; Ruiter JP; Simonsen H; Winter V; Knudsen I; Schroeder LD; Gregersen N; Skovby F
Am J Hum Genet; 2000 Nov; 67(5):1095-103. PubMed ID: 11013134
[TBL] [Abstract][Full Text] [Related]
35. The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase.
Ito M; Ikeda Y; Arnez JG; Finocchiaro G; Tanaka K
Biochim Biophys Acta; 1990 May; 1034(2):213-8. PubMed ID: 2112956
[TBL] [Abstract][Full Text] [Related]
36. Thermodynamic regulation of human short-chain acyl-CoA dehydrogenase by substrate and product binding.
Saenger AK; Nguyen TV; Vockley J; Stankovich MT
Biochemistry; 2005 Dec; 44(49):16043-53. PubMed ID: 16331964
[TBL] [Abstract][Full Text] [Related]
37. Mechanism-based inhibitor discrimination in the acyl-CoA dehydrogenases.
Schaller RA; Mohsen AW; Vockley J; Thorpe C
Biochemistry; 1997 Jun; 36(25):7761-8. PubMed ID: 9201918
[TBL] [Abstract][Full Text] [Related]
38. Identification of the catalytic base in long chain acyl-CoA dehydrogenase.
Djordjevic S; Dong Y; Paschke R; Frerman FE; Strauss AW; Kim JJ
Biochemistry; 1994 Apr; 33(14):4258-64. PubMed ID: 8155643
[TBL] [Abstract][Full Text] [Related]
39. Functional annotation of putative fadE9 of Mycobacterium tuberculosis as isobutyryl-CoA dehydrogenase involved in valine catabolism.
Rani N; Hazra S; Singh A; Surolia A
Int J Biol Macromol; 2019 Feb; 122():45-57. PubMed ID: 30316772
[TBL] [Abstract][Full Text] [Related]
40. Identification of the active site catalytic residue in human isovaleryl-CoA dehydrogenase.
Mohsen AW; Vockley J
Biochemistry; 1995 Aug; 34(32):10146-52. PubMed ID: 7640268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
